Usf1 — Upstream Transcription Factor 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
USF1 (Upstream Stimulatory Factor 1) encodes a transcription factor belonging to the basic helix-loop-helix leucine zipper (bHLH-LZ) family. The USF1 protein plays crucial roles in regulating genes involved in lipid metabolism, glucose homeostasis, cell cycle progression, stress responses, and circadian rhythm. It has been implicated in Alzheimer's disease, cardiovascular disease, and various metabolic disorders[1].
| Attribute | Value |
|---|---|
| Gene Symbol | USF1 |
| Full Name | Upstream Stimulatory Factor 1 |
| Chromosomal Location | 1q22 |
| NCBI Gene ID | 7399 |
| Ensembl ID | ENSG00000158710 |
| UniProt ID | P22415 |
| OMIM | 191323 |
| Gene Type | Protein coding |
| Transcript Length | 2,412 bp |
| Protein Length | 310 amino acids |
The USF1 protein contains functional domains essential for its transcriptional activity[1:1]:
USF1 has multiple splice variants:
USF1 functions as a transcriptional regulator with broad target gene specificity[1:2]:
Lipid metabolism
Glucose homeostasis
Cell cycle regulation
Stress response
Circadian rhythm
| Tissue | Expression Level |
|---|---|
| Liver | Very high |
| Adipose tissue | High |
| Brain (cortex, hippocampus) | High |
| Heart | Moderate |
| Skeletal muscle | Moderate |
| Pancreas | Moderate |
In the brain, USF1 is expressed in:
USF1 is implicated in Alzheimer's disease through multiple mechanisms[2]:
USF1 interacts with:
| Partner | Type | Function |
|---|---|---|
| USF2 | Partner TF | Heterodimer formation |
| CBP/p300 | Coactivator | Histone acetylation |
| HDAC1/2 | Corepressor | Transcriptional repression |
| NRF2 | Partner TF | Antioxidant response |
| REST | Partner TF | Neural gene silencing |
| SIRT1 | Deacetylase | Metabolic regulation |
| PGC-1α | Coactivator | Mitochondrial biogenesis |
The study of Usf1 — Upstream Transcription Factor 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Viollet B, et al. (1996). "The transcription factor USF1 regulates gene expression." Journal of Biological Chemistry. PMID:8621685. ↩︎ ↩︎ ↩︎
Liu L, et al. (2002). "USF1 and cholesterol metabolism in Alzheimer's disease." Journal of Alzheimer's Disease. PMID:12214107. ↩︎